AntibioticsRx (Retseptli)

Meropenem Avantika

Dosage form:Powder for solution for injection 1000mg vials
Category:Antibiotics

Indications for Use

- pneumonia

  • - urinary tract infection
  • - peritonitis
  • - abdominal (intra-abdominal) infections
  • - meningitis
  • - gynecological infections


Composition & Active Ingredient

Active Ingredient: MEROPENEM
Composition: MEROPENEM

Dosage & Administration

Dosage: 1000 mg
Usage Instructions: Method of administration and dosage: Adults: Intravenously, 1 g every 8 hours for the treatment of pneumonia, urinary tract infections, gynecological infections (endometritis), skin and skin structure infections. 1 g intravenously every 8 hours for the treatment of nosocomial pneumonia, peritonitis, suspected bacterial infection in patients with neutropenia symptoms, septicemia. For the treatment of meningitis, the recommended dose is 2 g every 8 hours. For the treatment of certain infections, particularly those caused by less sensitive pathogens (such as Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp.), or for very severe infections, the recommended dose is up to 2 g every 8 hours. Children: For children aged 3 months to 12 years, the recommended intravenous dose is 10–20 mg/kg every 8 hours, depending on the type and severity of the infection, the sensitivity of the pathogenic microorganism, and the patient's condition. In children weighing more than 50 kg, adult doses should be used. For meningitis, the recommended dose is 40 mg/kg every 8 hours. For the treatment of certain infections, particularly those caused by less sensitive pathogens (such as Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp.), or for very severe infections, the recommended dose is up to 40 mg/kg every 8 hours.

Contraindications

Contraindications: History of hypersensitivity to meropenem or other carbapenem-group drugs. Severe hypersensitivity (anaphylactic reactions, severe skin reactions) to any antibacterial agent with a beta-lactam structure (i.e., penicillins or cephalosporins). Children under 3 months of age. Use during pregnancy and breastfeeding: Meropenem should not be used during pregnancy, except in cases where the potential benefit to the mother outweighs the possible risk to the fetus. The potential benefit to the mother from using Meropenem outweighs the possible risk to the child during breastfeeding.

Storage & Packaging

Storage Conditions: Storage conditions: Store in a place protected from light at a temperature not exceeding 30°C.
Package Description: Dosage form and package: Powder for solution for injection 1000mg vials
PDF

Official Medical Leaflet

Approved PDF Document • Complete Prescribing Info

Open Medical Leaflet (PDF)

Medical Disclaimer: All information provided on this website is for educational purposes only and does not substitute professional medical advice. Consult a healthcare professional and read the official packaging insert before use.

Related Products